Stocks
Anika Therapeutics (ANIK) EV/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -106.3 | 20.7 | 19.3 | 70.4 | -19.6 | -28.5 | ||
| Changes by years, y/y, % | +141% | -119% | -7% | +264% | -128% | -15.0% | |||
Anika Therapeutics. EV/EBITDA
Anika Therapeutics. EV/EBITDA, changes, %
Anika Therapeutics (ANIK) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -139.7 | -29.0 | 5.28 | -19.8 | -27.3 | -28.5 | |
| Changes by years, y/y, % | +72% | -68% | -140% | -95% | -80% | |||
| Changes by quarters, q/q, % | -66% | -79% | -118% | -475% | +38% | |||
